Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Genital Herpes Treatment Market Size study, by Drug Type Distribution Channel Route of Administration Indication and Regional Forecasts 2021-2027

Published by Bizwit Research & Consulting LLP Product code 1019236
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Global Genital Herpes Treatment Market Size study, by Drug Type Distribution Channel Route of Administration Indication and Regional Forecasts 2021-2027
Published: July 17, 2021 Content info:
Description

Global Genital Herpes Treatment Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Herpes simplex virus (HSV) causes genital herpes, a sexually transmitted illness that is spread by infected people's sperm, saliva, and vaginal fluids. Herpes simplex viruses come in two varieties: HSV-1 and HSV-2. Blisters on the genital organs, blisters in the mouth, lips, and other regions, itching or tingling in the infected areas, pelvic discomfort, vaginal discharge, and other symptoms are all frequent genital herpes symptoms. Therapy options for genital herpes include medication, episodic treatment, and suppressive treatment, among others. Commercially available antiviral medications for the treatment of genital herpes include Acyclovir, Famciclovir, and Valacyclovir. Over the projected period, the rising frequency of sexually transmitted diseases, particularly genital herpes, is likely to drive demand for genital herpes therapy. According to the Centers for Disease Control and Prevention, genital herpes affects roughly 50 million people in the United States. During the projected period, factors such as rising genital herpes diagnosis rates in emerging nations and expanding clinical trials of genital herpes vaccines have further fueled the expansion of the genital herpes market. Sanofi Pasteur, for example, is working on a herpes vaccine called HSV529 in partnership with the National Institute of Allergy and Infectious Diseases. The vaccine is categorised as a replication-defective virus, which means it has all of the HSV virus's components minus two key proteins required in viral DNA replication, UL5 and UL29. GlaxoSmithKline plc started phase 1 human clinical trials for their investigational HSV-2 vaccine in March 2021, with the goal of determining the reactogenicity, safety, and immunogenicity of four different dosage levels of the vaccine in healthy adults aged 18 to 40. Furthermore, rising government support for the development of novel therapeutics for the treatment of genital herpes is expected to drive market expansion during the forecast period. Furthermore, in developed countries, accurate diagnostic techniques such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, and real-time PCR assays are widely utilized to identify STIs. These tests are effective for diagnosing asymptomatic infections, which will boost demand for genital herpes therapy and propel the industry forward. Inadequate reimbursement and a poor treatment seeking rate for genital herpes, on the other hand, will stifle market growth between 2021 and 2027. Although, throughout the forecast period, increasing demand for genital herpes treatment medicines by homosexuals presents a profitable opportunity for the market.

The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Genital Herpes Treatment market. Because of the significant growth of herpes cases in the region, North America is the world's top region in terms of market share. According to the Centers for Disease Control and Prevention, genital herpes affects one out of every six persons in the United States between the ages of 14 and 49. Whereas, Asia-Pacific is expected to expand at the fastest pace during the forecast period, as the region's quickly growing population, as well as increased awareness and diagnosis, would provide attractive potential opportunities for the Genital Herpes Treatment market.

Major market player included in this report are:

Teva Pharmaceutical Industries Ltd

Abbott Laboratories

Sun Pharmaceuticals Industries Ltd.

Mylan N.V.

Pfizer Inc.

GlaxoSmithKline plc

Dr. Reddy's Laboratories ltd.

Novartis AG

Valeant Pharmaceuticals International Inc.

Genocea Biosciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Acyclovir

Valacyclovir

Famciclovir

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

By Route of Administration:

Oral

Topical

Injectable

By Indication:

HSV-1

HSV-2

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Genital Herpes Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Genital Herpes Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Genital Herpes Treatment Market, by Drug Type, 2019-2027 (USD Billion)
    • 1.2.3. Genital Herpes Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
    • 1.2.4. Genital Herpes Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
    • 1.2.5. Genital Herpes Treatment Market, by Indication, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Genital Herpes Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Genital Herpes Treatment Market Dynamics

  • 3.1. Genital Herpes Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising frequency of sexually transmitted diseases
      • 3.1.1.2. Expanding clinical trials of genital herpes vaccines
    • 3.1.2. Market Challenges
      • 3.1.2.1. Inadequate reimbursement and a poor treatment seeking rate for genital herpes
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for genital herpes treatment medicines by homosexuals

Chapter 4. Global Genital Herpes Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Genital Herpes Treatment Market, by Drug Type

  • 5.1. Market Snapshot
  • 5.2. Global Genital Herpes Treatment Market by Drug Type, Performance - Potential Analysis
  • 5.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
  • 5.4. Genital Herpes Treatment Market, Sub Segment Analysis
    • 5.4.1. Acyclovir
    • 5.4.2. Valacyclovir
    • 5.4.3. Famciclovir

Chapter 6. Global Genital Herpes Treatment Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Genital Herpes Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
  • 6.4. Genital Herpes Treatment Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Retail Pharmacies
    • 6.4.3. Online Pharmacies
    • 6.4.4. Drug Stores

Chapter 7. Global Genital Herpes Treatment Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Genital Herpes Treatment Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
  • 7.4. Genital Herpes Treatment Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Topical
    • 7.4.3. Injectable

Chapter 8. Global Genital Herpes Treatment Market, by Indication

  • 8.1. Market Snapshot
  • 8.2. Global Genital Herpes Treatment Market by Indication, Performance - Potential Analysis
  • 8.3. Global Genital Herpes Treatment Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
  • 8.4. Genital Herpes Treatment Market, Sub Segment Analysis
    • 8.4.1. HSV-1
    • 8.4.2. HSV-2

Chapter 9. Global Genital Herpes Treatment Market, Regional Analysis

  • 9.1. Genital Herpes Treatment Market, Regional Market Snapshot
  • 9.2. North America Genital Herpes Treatment Market
    • 9.2.1. U.S. Genital Herpes Treatment Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. Indication breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Genital Herpes Treatment Market
  • 9.3. Europe Genital Herpes Treatment Market Snapshot
    • 9.3.1. U.K. Genital Herpes Treatment Market
    • 9.3.2. Germany Genital Herpes Treatment Market
    • 9.3.3. France Genital Herpes Treatment Market
    • 9.3.4. Spain Genital Herpes Treatment Market
    • 9.3.5. Italy Genital Herpes Treatment Market
    • 9.3.6. Rest of Europe Genital Herpes Treatment Market
  • 9.4. Asia-Pacific Genital Herpes Treatment Market Snapshot
    • 9.4.1. China Genital Herpes Treatment Market
    • 9.4.2. India Genital Herpes Treatment Market
    • 9.4.3. Japan Genital Herpes Treatment Market
    • 9.4.4. Australia Genital Herpes Treatment Market
    • 9.4.5. South Korea Genital Herpes Treatment Market
    • 9.4.6. Rest of Asia Pacific Genital Herpes Treatment Market
  • 9.5. Latin America Genital Herpes Treatment Market Snapshot
    • 9.5.1. Brazil Genital Herpes Treatment Market
    • 9.5.2. Mexico Genital Herpes Treatment Market
  • 9.6. Rest of The World Genital Herpes Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceutical Industries Ltd
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Abbott Laboratories
    • 10.2.3. Sun Pharmaceuticals Industries Ltd.
    • 10.2.4. Mylan N.V.
    • 10.2.5. Pfizer Inc.
    • 10.2.6. GlaxoSmithKline plc
    • 10.2.7. Dr. Reddy's Laboratories ltd.
    • 10.2.8. Novartis AG
    • 10.2.9. Valeant Pharmaceuticals International Inc.
    • 10.2.10. Genocea Biosciences

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Genital Herpes Treatment market, report scope
  • TABLE 2. Global Genital Herpes Treatment market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Genital Herpes Treatment market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
  • TABLE 4. Global Genital Herpes Treatment market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
  • TABLE 5. Global Genital Herpes Treatment market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
  • TABLE 6. Global Genital Herpes Treatment market estimates & forecasts by Indication 2018-2027 (USD Billion)
  • TABLE 7. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Genital Herpes Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Genital Herpes Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. U.S. Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Canada Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. Canada Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. UK Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. UK Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Germany Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Germany Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. RoE Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. RoE Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. China Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. China Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. India Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. India Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Japan Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Japan Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. Brazil Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Brazil Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Mexico Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Mexico Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. RoLA Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. RoLA Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Genital Herpes Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Row Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Row Genital Herpes Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Genital Herpes Treatment market
  • TABLE 57. List of primary sources, used in the study of global Genital Herpes Treatment market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Genital Herpes Treatment market, research methodology
  • FIG 2. Global Genital Herpes Treatment market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Genital Herpes Treatment market, key trends 2020
  • FIG 5. Global Genital Herpes Treatment market, growth prospects 2021-2027
  • FIG 6. Global Genital Herpes Treatment market, porters 5 force model
  • FIG 7. Global Genital Herpes Treatment market, pest analysis
  • FIG 8. Global Genital Herpes Treatment market, value chain analysis
  • FIG 9. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Genital Herpes Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Genital Herpes Treatment market, regional snapshot 2018 & 2027
  • FIG 15. North America Genital Herpes Treatment market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Genital Herpes Treatment market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Genital Herpes Treatment market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Genital Herpes Treatment market 2018 & 2027 (USD Billion)
  • FIG 19. Global Genital Herpes Treatment market, company market share analysis (2020)
Back to Top